BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25176379)

  • 1. Effects of various excipients on tizanidine hydrochloride tablets prepared by direct compression.
    Khan LG; Razvi N; Anjum F; Siddiqui SA; Ghayas S
    Pak J Pharm Sci; 2014 Sep; 27(5):1249-54. PubMed ID: 25176379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation development and optimization studies of mouth dissolving tablets of tizanidine HCl.
    Iqbal H; Naz S; Ali H; Bashir L; Zafar F; Akram S; Yasmin R; Ghayas S; Israr F; Akifuddin -
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):245-251. PubMed ID: 32122855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous direct tablet compression: effects of impeller rotation rate, total feed rate and drug content on the tablet properties and drug release.
    Järvinen MA; Paaso J; Paavola M; Leiviskä K; Juuti M; Muzzio F; Järvinen K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1802-8. PubMed ID: 23163644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a continuous twin screw granulation and drying system during formulation development and process optimization.
    Vercruysse J; Peeters E; Fonteyne M; Cappuyns P; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Jan; 89():239-47. PubMed ID: 25528462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluations of buccal tablet formulations of ritodrine hydrochloride.
    Onishi H; Sakata O; Yumoto K
    Biol Pharm Bull; 2015; 38(6):919-25. PubMed ID: 26027834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compression parameters of hexagonal boron nitride on direct compression mixture of microcrystalline cellulose and modified starch.
    Halaçoğlu MD; Uğurlu T
    Pharm Dev Technol; 2015; 20(6):747-54. PubMed ID: 24841191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach.
    Castillo Henríquez L; Vargas Zúñiga R; Carazo Berrocal G; Madrigal Redondo G; Calvo Guzmán B; Baltodano Viales E
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1674-1681. PubMed ID: 31378098
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design.
    Martinello T; Kaneko TM; Velasco MV; Taqueda ME; Consiglieri VO
    Int J Pharm; 2006 Sep; 322(1-2):87-95. PubMed ID: 16806756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of polymer type on the physical properties and the release study of papaverine hydrochloride from tablets].
    Kasperek R; Polski A; Sobótka-Polska K; Poleszak E
    Polim Med; 2014; 44(1):5-12. PubMed ID: 24918651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development and optimization of Ibuprofen tablets by direct compression method.
    Bushra R; Shoaib MH; Aslam N; Hashmat D; Ur-Rehman M
    Pak J Pharm Sci; 2008 Apr; 21(2):113-20. PubMed ID: 18390440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
    Yang B; Wei C; Yang Y; Wang Q; Li S
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Solid Self-Microemulsifying System of Tizanidine Hydrochloride for Oral Bioavailability Enhancement: In Vitro and In Vivo Evaluation.
    Pramanik S; Thakkar H
    AAPS PharmSciTech; 2020 Jul; 21(5):182. PubMed ID: 32613377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of binding potential of Prunus armeniaca and Prunus domestica gums in tablets formulations.
    Rahim H; Khan MA; Sadiq A; Khan S; Chishti KA; Rahman IU
    Pak J Pharm Sci; 2015 May; 28(3):909-14. PubMed ID: 26004724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.